Pharmacokinetics and pharmacodynamics (PK/PD) of human brain natriuretic peptide (hBNP) in patients with congestive heart failure (CHF).

被引：0
|
作者：
Kastrissios, H
Katz, SD
Grossbard, EB
Allgren, RL
Sambol, NC
机构：
[1] UNIV CALIF SAN FRANCISCO, DEPT BIOPHARM SCI, SAN FRANCISCO, CA 94143 USA
[2] SCIOS, MT VIEW, CA USA
[3] COLUMBIA PRESBYTERIAN MED CTR, NEW YORK, NY 10032 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1997年 / 61卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：PIV47 / PIV47
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetics/pharmacodynamics (PK/PD) of nesiritide in patients with congestive heart failure (CHF).
    Sambol, NC
    Liu, CY
    Horton, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P90 - P90
  • [2] Brain Natriuretic Peptide (BNP) Suppresses Neutrophil Superoxide Release: Attenuation in Patients with Congestive Heart Failure (CHF)
    Liu, Saifei
    Ngo, Doan T.
    Chirkov, Yuliy Y.
    Sheikh, Abdul R.
    Licari, Giovanni
    Stewart, Simon
    Horowitz, John D.
    CIRCULATION, 2012, 126 (21)
  • [3] INCREASED HUMAN BRAIN NATRIURETIC PEPTIDE IN CONGESTIVE HEART-FAILURE
    MUKOYAMA, M
    NAKAO, K
    SAITO, Y
    OGAWA, Y
    HOSODA, K
    SUGA, SI
    SHIRAKAMI, G
    JOUGASAKI, M
    IMURA, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (11): : 757 - 758
  • [4] Renal effects of brain natriuretic peptide in patients with congestive heart failure
    Jensen, KT
    Eiskjæer, H
    Carstens, J
    Pedersen, EB
    CLINICAL SCIENCE, 1999, 96 (01) : 5 - 15
  • [5] Pharmacokinetics/pharmacodynamics (PK/PD) meta-analysis for levosimendan in patients with heart failure
    Noertersheuser, Peter
    Pradhan, Rajendra
    Mandema, Jaap
    Zhang, Wenhin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1199 - 1199
  • [6] ATRIAL-NATRIURETIC-PEPTIDE (ANF) KINETICS IN PATIENTS WITH CONGESTIVE HEART-FAILURE (CHF)
    HENSEN, J
    DURR, JA
    ABRAHAM, WT
    LESNEFSKY, E
    GROVES, B
    LINDENFELD, J
    GANOUSIS, L
    SCHRIER, RW
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 275 - 275
  • [7] Pharmacokinetics (PK) and pharmacodynamics (PD) of toborinone in CHF patients during continuous infusion.
    Tammara, B
    Cowart, D
    Bramer, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 212 - 212
  • [8] Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
    Koglin, J
    Pehlivanli, S
    Schwaiblmair, M
    Vogeser, M
    Cremer, P
    von Scheidt, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 1934 - 1941
  • [9] Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea
    Carmona-Bernal, C
    Quintana-Gallego, E
    Villa-Gil, M
    Sánchez-Armengol, A
    Martínez-Martínez, A
    Capote, F
    CHEST, 2005, 127 (05) : 1667 - 1673
  • [10] Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure
    Tsutamoto, T
    Wada, A
    Maeda, K
    Hisanaga, T
    Fukai, D
    Maeda, Y
    Ohnishi, M
    Mabuchi, N
    Kinoshita, M
    AMERICAN HEART JOURNAL, 1997, 134 (05) : 910 - 916
12345